News

Recently, Shanghai Step Medical Technology Co., Ltd. announced the completion of RMB 350 million in Series B financing, setting a record for the highest single financing in China's implantable brain-computer interface industry.

This round of financing was led by well-known institutions such as Qiming Venture Partners, Orbis Capital, and Lilly Asia Funds, and angel round investor Source Capital continued to follow up, with Qifeng Capital serving as financial advisor.

Founded in 2021, Step Medical focuses on the research and development and clinical application transformation of implantable brain-computer interface technology. This round of funds will be used to accelerate product clinical trials, new generation technology research and development, and the construction of medical-grade MEMS production bases, further promoting the commercialization of brain-computer interface technology.

Previously, Step Medical had obtained hundreds of millions of yuan in Series A financing and tens of millions of yuan in angel round financing, demonstrating its strong development momentum in the field of brain-computer interface.